home / stock / clsd / clsd quote
Last: | $1.145 |
---|---|
Change Percent: | -0.43% |
Open: | $1.18 |
Close: | $1.15 |
High: | $1.18 |
Low: | $1.12 |
Volume: | 34,556 |
Last Trade Date Time: | 07/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.145 | $1.18 | $1.15 | $1.18 | $1.12 | 34,556 | 07-24-2024 |
$1.15 | $1.14 | $1.15 | $1.185 | $1.13 | 97,612 | 07-23-2024 |
$1.13 | $1.19 | $1.13 | $1.19 | $1.12 | 107,610 | 07-22-2024 |
$1.17 | $1.17 | $1.17 | $1.19 | $1.15 | 62,192 | 07-19-2024 |
$1.15 | $1.23 | $1.15 | $1.23 | $1.11 | 158,791 | 07-18-2024 |
$1.21 | $1.25 | $1.21 | $1.25 | $1.16 | 123,962 | 07-17-2024 |
$1.22 | $1.26 | $1.22 | $1.26 | $1.18 | 185,470 | 07-16-2024 |
$1.24 | $1.24 | $1.24 | $1.26 | $1.2 | 145,436 | 07-15-2024 |
$1.25 | $1.22 | $1.25 | $1.26 | $1.2 | 148,732 | 07-12-2024 |
$1.21 | $1.25 | $1.21 | $1.2782 | $1.18 | 195,286 | 07-11-2024 |
$1.23 | $1.26 | $1.23 | $1.27 | $1.21 | 88,857 | 07-10-2024 |
$1.26 | $1.28 | $1.26 | $1.3 | $1.2 | 163,716 | 07-09-2024 |
$1.25 | $1.28 | $1.25 | $1.28 | $1.21 | 147,777 | 07-08-2024 |
$1.28 | $1.26 | $1.28 | $1.28 | $1.215 | 125,741 | 07-05-2024 |
$1.27 | $1.23 | $1.27 | $1.28 | $1.23 | 49,073 | 07-04-2024 |
$1.27 | $1.23 | $1.27 | $1.28 | $1.23 | 49,073 | 07-03-2024 |
$1.23 | $1.25 | $1.23 | $1.25 | $1.21 | 91,427 | 07-02-2024 |
$1.24 | $1.29 | $1.24 | $1.29 | $1.2099 | 79,245 | 07-01-2024 |
$1.3 | $1.28 | $1.3 | $1.31 | $1.26 | 110,201 | 06-28-2024 |
$1.28 | $1.22 | $1.28 | $1.28 | $1.2105 | 96,813 | 06-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
Clearside Biomedical Inc. Company Name:
CLSD Stock Symbol:
NASDAQ Market:
Clearside Biomedical Inc. Website:
ALPHARETTA, Ga., July 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), has opened registration for its virtual key opinion l...
ALPHARETTA, Ga., July 11, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today the appointment of Glenn C. Yiu, M.D....
- Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET - - Retina Specialists to Provide Insights and Real-World Experience with Suprachoroidal Drug Delivery - - Target Profile for CLS-AX in Wet AMD Landscape and Potential Opportunities for Clearside Pipeline Expansion - ...